Casirivimab is a specialty medication, which means it's costly and requires more steps than usual in order to get it. We break down the process for you.
If you've been prescribed Casirivimab or are considering it, we'll walk you through what you need to know about this specialty medication.
About casirivimab
Casirivimab is an investigational monoclonal antibody therapy authorized for emergency use by the FDA to treat COVID-19. It must be administered together with imdevimab. It is not yet FDA approved, and the safety and effectiveness of this therapy is still being evaluated.